Products
Platform
Research
Market
Learn
Compare Quant Healthcare Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹1000 | ₹500 |
Expense Ratio | 2.4 | 1.93 |
NAV | ₹15.54 | ₹440.46 |
Fund Started | 27 Jun 2023 | 04 Jun 1999 |
Fund Size | ₹378.86 Cr | ₹3933.26 Cr |
Exit Load | Exit load of 1%, if redeemed within 15 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹1000
₹500
Expense Ratio
2.4
1.93
NAV
₹15.54
₹440.46
Fund Started
27 Jun 2023
04 Jun 1999
Fund Size
₹378.86 Cr
₹3933.26 Cr
Exit Load
Exit load of 1%, if redeemed within 15 days.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | -4.43% | 8.15% |
3 Year | - | 25.95% |
5 Year | - | 19.96% |
1 Year
-4.43%
8.15%
3 Year
-
25.95%
5 Year
-
19.96%
Holding Analysis
Equity | 94.61% | 96.36% |
Cash | 1.21% | 3.56% |
Equity
94.61%
96.36%
Cash
1.21%
3.56%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Aster DM Healthcare Ltd. | 10.37% |
RPG Life Sciences Ltd. | 8.88% |
Zydus Wellness Ltd. | 7.74% |
Sequent Scientific Ltd. | 7.26% |
Anthem Biosciences Ltd. | 6.70% |
Lupin Ltd. | 6.68% |
Pfizer Ltd. | 6.37% |
Aurobindo Pharma Ltd. | 6.22% |
Alivus Life Sciences Ltd | 6.04% |
HDFC Life Insurance Co Ltd. | 5.94% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.94% |
Divi's Laboratories Ltd. | 6.36% |
Max Healthcare Institute Ltd. | 5.67% |
Cipla Ltd. | 4.59% |
Lupin Ltd. | 4.08% |
Lonza Group Ag | 4.06% |
Fortis Healthcare Ltd. | 3.70% |
Torrent Pharmaceuticals Ltd. | 3.66% |
Gland Pharma Ltd. | 3.54% |
Mankind Pharma Ltd. | 3.34% |
Fund Manager
Name | Ankit A Pande | Tanmaya Desai |
Start Date | 07 Jul 2025 | 17 May 2024 |
Name
Ankit A Pande
Tanmaya Desai
Start Date
07 Jul 2025
17 May 2024
About Fund
Description | The scheme seeks to long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 27 Jun 2023 | 04 Jun 1999 |
Description
The scheme seeks to long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
27 Jun 2023
04 Jun 1999